To determine whether CCL5 secretion varies among breast cancer cells, we tested media conditioned by breast cancer cell lines that are commonly used to model distinct breast cancer types, including luminal (MCF7), HER2+ (SKBr3), and triple negative (MDA-MB 231) breast cancers. The gene discussed is ERBB2; the disease is breast carcinoma.